Search

Search Constraints

You searched for: Author/Creator Mosini, Giulia

Search Results

1. Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn's disease patients with perianal lesions: a systematic review. (3rd March 2020)

2. The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database. (2nd September 2021)

3. The use of biological agents in pregnant women affected by autoimmune disorders: Why we need more research of this neglected area. (September 2021)

4. Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis. (4th May 2022)

5. Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: a pharmacovigilance-pharmacodynamic/pharmacokinetic assessment through an analysis of the vigibase®. Issue 11 (2nd November 2019)

6. Reply to: correspondence on "Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis​". (3rd August 2022)

7. Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: a network meta-analysis and regression. Issue 15 (24th November 2022)

9. Beta‐blocker‐associated hypoglycaemia: New insights from a real‐world pharmacovigilance study. Issue 8 (23rd February 2021)

10. Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility. Issue 9 (2nd September 2021)